Workflow
Bondex(603836)
icon
Search documents
海程邦达供应链管理股份有限公司关于使用暂时闲置募集 资金进行现金管理到期赎回并继续进行现金管理的进展公告
Core Viewpoint - The company is utilizing part of its idle raised funds for cash management to enhance fund efficiency and generate returns while ensuring the safety of the funds and not affecting the implementation of fundraising projects [2][5][11]. Group 1: Fund Management and Investment - The company has approved the use of idle raised funds for cash management, with a total investment amount of RMB 13,000 million [5][6]. - The funds are sourced from idle raised funds, specifically for purchasing high-security, liquid principal-protected financial products [6][7]. - Recent cash management activities include the redemption of structured deposits and investment products, yielding a total return of RMB 56.07 million from two investments [3][4]. Group 2: Financial Performance and Impact - As of September 30, 2025, the company's cash balance was RMB 96,305 million, with the cash management investment representing 13.50% of this amount, indicating a manageable impact on the company's financial status [11]. - The cash management strategy is designed to improve the efficiency of raised funds without disrupting the normal operations of the company's main business [11]. Group 3: Risk Management - The company acknowledges potential risks associated with market fluctuations and macroeconomic changes but emphasizes that the selected financial products are of high security and liquidity [2][9]. - Risk control measures include close monitoring of the financial products and the ability to take timely actions if adverse factors are identified [10].
海程邦达:关于使用暂时闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告
Zheng Quan Ri Bao· 2026-02-13 12:44
(文章来源:证券日报) 证券日报网讯 2月13日,海程邦达发布公告称,公司使用暂时闲置募集资金13,000万元购买上海浦东 发展银行利多多公司稳利26JG5743期(三层看涨)人民币对公结构性存款,期限60天,预计年化收益 率0.70%或1.82%或2.02%,截至本公告日最近12个月累计尚未到期产品余额20,000万元。 ...
海程邦达(603836) - 关于使用暂时闲置募集资金进行现金管理到期赎回并继续进行现金管理的进展公告
2026-02-13 09:15
证券代码:603836 证券简称:海程邦达 公告编号:2026-014 一、本次募集资金现金管理到期赎回情况 1、2025 年 11 月 12 日,公司下属全资子公司使用部分闲置募集资金向上海 浦东发展银行股份有限公司青岛分行购买人民币 11,000 万元的利多多公司稳利 99JG0335 期(三层看涨)人民币对公结构性存款,该理财产品已到期赎回,公司收 回本金 11,000 万元,获得理财收益 50.88 万元,本金及收益均已全部划至募集资 金专用账户。 2、2025 年 11 月 21 日,公司下属全资子公司使用部分闲置募集资金向国泰 海通证券股份有限公司购买人民币 2,000 万元的国泰海通证券君跃飞龙伍佰定制 1 投资种类:银行结构性存款 投资金额:人民币 13,000 万元 海程邦达供应链管理股份有限公司 关于使用暂时闲置募集资金进行现金管理到期赎回并继续进行现金 管理的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示: 已履行及拟履行的审议程序:海程邦达供应链管理股份有限公司(以 下简称"公司 ...
海程邦达股价震荡,物流行业数据向好
Jing Ji Guan Cha Wang· 2026-02-13 03:29
经济观察网海程邦达(603836)近7天股价呈现震荡走势。截至2026年2月12日收盘,股价报14.77元, 当日下跌1.53%,成交额4092.64万元;主力资金净流入64.95万元,游资资金净流入125.79万元,散户资 金净流出137.19万元。近5日股价振幅为8.07%,技术面显示20日压力位在15.11元,支撑位在13.86元, MACD指标处于多头区间,但KDJ指标提示短期超买风险。整体表现强于物流行业平均水平(近5日行业 跌幅0.70%),但需关注资金流向持续性。 近期事件 以上内容基于公开资料整理,不构成投资建议。 机构观点 当前机构对海程邦达关注度较低,舆情偏中性。根据最新市场观点,该股机构调研频率行业排名靠后 (37/129),基金持股比例仅0.15%,评级以中性为主。需警惕盈利质量恶化风险,如2025年三季报显示 毛利率降至6.33%,但第三季度归母净利润同比回升44.26%,后续需观察高价值业务突破进展。 2026年2月11日,中国物流与采购联合会发布数据显示,2025年全国社会物流总额达368.2万亿元,同比 增长5.1%,各季度增速保持稳定。其中,工业品物流额增长5.3%,装备制造 ...
海程邦达供应链管理股份有限公司董事减持计划完成暨减持股份结果公告
Summary of Key Points Core Viewpoint - The company has disclosed the completion of a share reduction plan by its director, Wang Xiping, who has reduced his holdings in the company. Group 1: Shareholding Information - Before the reduction plan, Wang Xiping directly held 7,936,100 shares, accounting for 3.87% of the total shares of the company [1] - Wang Xiping also indirectly holds 10,597,109 shares through Ningbo Fanruida Venture Capital Partnership, bringing his total shareholding to 9.03% of the company [1] Group 2: Reduction Plan Implementation - The reduction plan was announced on November 14, 2025, with Wang Xiping intending to reduce his holdings by up to 1,984,000 shares, which is 0.97% of the total shares, between December 5, 2025, and March 4, 2026 [1] - As of the announcement date, Wang Xiping has successfully reduced his holdings by 1,984,000 shares, completing the reduction plan [1][3] - The company confirmed that the reduction adhered to relevant laws and regulations, and the actual reduction was consistent with the previously disclosed plan [3]
海程邦达:董事减持计划完成暨减持股份结果公告
Zheng Quan Ri Bao· 2026-02-03 13:40
证券日报网讯 2月3日,海程邦达发布公告称,公司董事王希平于2025年12月5日至2026年2月2日通过集 中竞价减持1984000股,占总股本0.97%,减持价格区间为14.18元/股~16.02元/股,减持总金额为 29197065元,减持计划实施完毕。 (文章来源:证券日报) ...
2月3日晚间重要公告一览
Xi Niu Cai Jing· 2026-02-03 10:11
Group 1 - Fulin Precision's subsidiary Jiangxi Shenghua invested 270 million yuan to establish a joint venture for a 500,000-ton ferrous oxalate project, with a total investment of 1.5 billion yuan expected to be completed by September 30, 2026 [1] - Xuguang Electronics plans to raise up to 1 billion yuan through a private placement to fund high-voltage vacuum arc extinguishing chamber expansion and other projects [2] - Minexplosion Optoelectronics intends to acquire 100% equity of Xiazhi Precision, with the transaction subject to shareholder and regulatory approvals [3] Group 2 - Shangluo Electronics' controlling shareholder plans to reduce his stake by up to 3% due to personal financial needs [4] - Babi Food reported a 1.3% decline in net profit for 2025, despite an 11.22% increase in revenue [5] - Pengding Holdings' subsidiary acquired industrial land in Huai'an for 66.14 million yuan [6] Group 3 - Zhuoyue New Energy's net profit for 2025 increased by 14.16%, despite a 17.43% decline in revenue [7] - Zhongyuan Media's net profit grew by 30.99% in 2025, with revenue decreasing by 5.13% [8] - Huangshan Tourism plans to invest approximately 530 million yuan in a hotel project with a 24-month construction period [9] Group 4 - *ST Jinling's restructuring plan was approved by the court, which may improve the company's financial situation [11] - Jichuan Pharmaceutical's subsidiary paid 80 million yuan for exclusive commercialization rights of a drug [12] - Pilin Bio's subsidiary received a notice for the acceptance of a drug supplement application [13] Group 5 - Nepe Mining terminated its investment in Swiss Veritas Resources AG due to changes in conditions [14] - Jinhui Wine announced a cash dividend of 0.20 yuan per share for the first three quarters of 2025 [15] - Hualan Biological's clinical trial for a new drug received approval for an additional indication [16] Group 6 - Industrial Fulian reported a total of 247 million yuan spent on share buybacks as of January 31, 2026 [17] - Yitong Century was pre-selected for a 107 million yuan project with China Tower [18] - Wanfeng Co. noted uncertainty in future price changes for disperse dyes [19] Group 7 - Bibet's clinical trial application for a new drug was approved by the National Medical Products Administration [21] - Chengbang Co. signed new project contracts worth 40.03 million yuan in Q4 2025 [22] - *ST Hengji received a court ruling for a performance compensation of 175 million yuan [23] Group 8 - Jihua Group is planning a change in control, leading to continued stock suspension [24] - Ningbo Port expects a container throughput of 5.03 million TEUs in January 2026, a 9.5% increase [25] - Hengli Petrochemical's actual controller increased his stake by 3.3 million shares [26] Group 9 - Hongfuhan signed a sales contract worth 480 million yuan with Guangdong Quanxiang [27] - All New Good's shareholder lifted a judicial freeze on 4.36% of the company's shares [28] - Changchun High-tech's subsidiary's clinical trial application for a new drug was accepted [29] Group 10 - Xingqi Eye Medicine's clinical trial for a new drug entered the first/second phase [31] - Hanma Technology reported a 140.04% increase in new energy heavy truck production in January 2026 [32] - Hengfeng Paper plans to invest 349 million yuan in a new green printing project [33] Group 11 - Zhifei Biological's mRNA vaccine for shingles received clinical trial approval [34] - Yutong Bus reported a 15.35% decrease in production in January 2026 [35] - StarNet Ruijie plans to sign a lease contract with an affiliate for a total rent of up to 110 million yuan [36] Group 12 - Hacheng Bonda's director completed a 0.97% share reduction [37] - Hendi Pharmaceutical's application for a new drug was approved [38] - Xinhua Medical's subsidiary received a medical device registration certificate [40] Group 13 - Yaokang Bio reported a 31.49% increase in net profit for 2025 [41] - Gaotie Electric reported a 14.02% increase in net profit for 2025 [42]
海程邦达(603836) - 董事减持计划完成暨减持股份结果公告
2026-02-03 08:01
重要内容提示: 董事持股的基本情况 本次减持计划实施前,海程邦达供应链管理股份有限公司(以下简称"公 司")董事王希平先生直接持有公司股份 7,936,100 股,占公司股份总数的 3.87%。 减持计划的实施结果情况 2025 年 11 月 14 日,公司披露了《海程邦达供应链管理股份有限公司董 事减持股份计划公告》(公告编号:2025-078),王希平先生拟自 2025 年 12 月 5 日至 2026 年 3 月 4 日期间通过集中竞价交易或大宗交易方式减持公司股 份不超过 1,984,000 股,占公司股份总数的 0.97%。 证券代码:603836 证券简称:海程邦达 公告编号:2026-013 海程邦达供应链管理股份有限公司 董事减持计划完成暨减持股份结果公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担法律责任。 截至本公告披露日,王希平先生通过集中竞价交易方式减持 1,984,000 股, 占公司股份总数的 0.97%,减持计划实施完毕。 股东名称 王希平 股东身份 控股股东、实控人及一致行动人 □是 √否 ...
海程邦达:董事王希平完成减持0.97%
Cai Jing Wang· 2026-02-03 07:59
海程邦达公告,董事王希平于2025年12月5日至2026年2月2日通过集中竞价减持198.4万股,占公司股份 总数0.97%,成交价14.18~16.02元/股,减持总金额2919.71万元;减持前直接持股793.61万股,占 3.87%,减持后持股595.21万股,占2.90%。此前披露的减持计划上限同为198.4万股,占0.97%,现已实 施完毕。 ...
海程邦达:关于以集中竞价交易方式回购股份的进展公告
Zheng Quan Ri Bao· 2026-02-02 12:40
(文章来源:证券日报) 证券日报网讯 2月2日,海程邦达发布公告称,2026年1月,公司未实施股份回购。截至2026年1月31 日,公司通过集中竞价交易方式已累计回购股份3,983,300股,占公司总股本的比例为1.94%。 ...